Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Debiopharm Extends Their DNA Damage Repair Footprint With New Oncology Pipeline Entry
Debiopharm, an independent Swiss-based, biopharmaceutical company aiming to develop tomorrow’s standard-of-care treatments to cure cancer […]
Echosens and Novo Nordisk Announce Partnership to Increase Awareness and Advance Early Diagnosis of NASH
Echosens, a high-technology company offering liver diagnostic solutions, and Novo Nordisk A/S, a leading global […]
Ginkgo Bioworks and Novo Nordisk to Collaborate on Expression Systems for Pharmaceutical Products
Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced a collaboration with Novo […]
Novo Nordisk Receives Fda Approval of Higher-dose Ozempic® 2 Mg Providing Increased Glycemic Control for Adults With Type 2 Diabetes
Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a […]
Novo Nordisk Expands Research Collaboration in Novel Delivery Technologies for Biologic Medicines
Novo Nordisk today announced the expansion of its existing research collaboration in oral drug delivery […]
Novo Nordisk to Acquire Dicerna Pharmaceuticals Including the RNAi Research Technology Platform
Novo Nordisk today announced that it has entered into a definitive agreement to acquire Dicerna […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more